Skip to content

Clinical trials

Completed Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Status: Completed Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20034
20044
20054
20066
20072
20082
20104
20112
20127
20132
20144
20153
20161
20173
20183
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Genzyme, a Sanofi Company6
European Organisation for Research and Treatment of Cancer - EORTC3
Sanofi3
Exelixis2
Massachusetts General Hospital2
Amgen1
Aristotle University Of Thessaloniki1
Austral University, Argentina1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary65
Thyroid Neoplasms29
Thyroid Cancer, Papillary17
Adenocarcinoma, Follicular16
Head and Neck Neoplasms12
Thyroid Carcinoma, Anaplastic12
Colonic Neoplasms10
Salivary Gland Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Carcinoma, Hepatocellular8

Trials

Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.